Bio

Yiming Liu is partner in charge of Cooley's Shanghai office. Yiming focuses his practice on capital markets and represents companies and investment funds on strategic transactions in the life sciences and technology industries. He regularly advises clients on the structuring, negotiation and documentation of a wide range of cross-border transactions, including mergers and acquisitions, private equity investments, venture financings, joint ventures, licensing and collaboration arrangements. In addition, Yiming is widely recognized for his work on life sciences and healthcare IPOs in Hong Kong and the US. In particular, he is adept in leading the compilation of offering documents and the communications with issuers, underwriters, investors and regulators during the listing processes. With advanced degrees in molecular, cellular and developmental biology and health services administration, Yiming leverages his technical background to help clients achieve their desired results. Yiming was recognized as one of "2022 ALB China Top 15 Capital Markets Lawyers" and one of "2022 ALB China Top 15 Rising Lawyers", both ranked by Thomson Reuters, Asian Legal Business (ALB).